Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
February 2012 Vol 5, No 1, Special Issue
Conference Highlights ASH
High Morbidity Burden Borne Years Later by Survivors of Transplant
Caroline Helwick
,
Caroline Helwick
Read More
Leukemia
Obinutuzumab Could Give Rituximab a Run for Its Money in Relapsed Indolent NHL
Read More
Leukemia
Maintenance Rituximab May Be Unnecessary in FL
Caroline Helwick
,
Caroline Helwick
Read More
Multiple Myeloma
,
Multiple Myeloma
Monoclonal Antibody Elotuzumab Promising in Multiple Myeloma
Read More
Multiple Myeloma
,
Multiple Myeloma
,
Multiple Myeloma
Pomalidomide a Promising New Immunomodulatory Drug for Multiple Myeloma
Read More
Leukemia
Investigational Blinatumomab Puts BiTE on Acute Lymphoblastic Leukemia
Neil Canavan
Read More
Radiologic Surveillance for Early-Stage Hodgkin Lymphoma an Unnecessary Expense?
Caroline Helwick
,
Caroline Helwick
Read More
A Large Study Sheds Light on the Cost of Managing NHL
Caroline Helwick
Read More
Second-Generation TKIs Have Potential to Cure CML
Read More
Hematologists Are Told to Get Ready for ACOs
Neil Canavan
,
Neil Canavan
Read More
1
2
3
Page 2 of 3
Results 11 - 20 of 29